http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016121165-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d5de9a1dac6b033c4643bb236ef4df3 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 |
| filingDate | 2016-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4caccdd39af3da89b0b530373d5e24af |
| publicationDate | 2016-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2016121165-A |
| titleOfInvention | Composition comprising a fusion protein or polypeptide derived from prosaposin for application to a transmembrane drug delivery system |
| abstract | A method for delivering an agent (eg, a pharmaceutical agent, a therapeutic agent, or an imaging agent) through a biological membrane. A method of delivering an agent using a fusion protein into and / or through skin membranes, mucous membranes and other cell membranes and through the vascular brain barrier. Liposomes can include dioleoylphosphatidylserine, a negatively charged long chain lipid. One or more phospholipids consisting of anionic long chain phospholipids with or without neutral phospholipids, short chain lipids or mixtures thereof, and a safe and effective amount of a pharmaceutical agent contained within the phospholipids; And a fusion protein or polypeptide derived from prosasin in a pharmaceutically acceptable carrier. A composition that forms a liposome capable of fusing with a target biological membrane. It is desirable that the liposome further contains a cationic phospholipid. The active factor contained in the liposome is a composition containing a biomolecule and / or an organic molecule. [Selection figure] None |
| priorityDate | 2006-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 931.